# A Study Assessing Arrhythmia Mapping With the Multi-Electrode OPTRELL™ Mapping Catheter

> **NCT04983797** · NA · COMPLETED · sponsor: **Biosense Webster, Inc.** · enrollment: 31 (actual)

## Conditions studied

- Scar-related Atrial Tachycardia
- Paroxysmal Atrial Fibrillation
- Persistent Atrial Fibrillation
- Tachycardia, Ventricular
- Ventricular Premature Complexes

## Interventions

- **DEVICE:** OPTRELL Mapping Catheter

## Key facts

- **NCT ID:** NCT04983797
- **Lead sponsor:** Biosense Webster, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-25
- **Primary completion:** 2021-11-04
- **Final completion:** 2021-11-04
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2023-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04983797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04983797, "A Study Assessing Arrhythmia Mapping With the Multi-Electrode OPTRELL™ Mapping Catheter". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04983797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*